Cargando…
Choroidal Thickness Analysis in Patients with Usher Syndrome Type 2 Using EDI OCT
To portray Usher Syndrome type 2, analyzing choroidal thickness and comparing data reported in published literature on RP and healthy subjects. Methods. 20 eyes of 10 patients with clinical signs and genetic diagnosis of Usher Syndrome type 2. Each patient underwent a complete ophthalmologic examina...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449934/ https://www.ncbi.nlm.nih.gov/pubmed/26075083 http://dx.doi.org/10.1155/2015/189140 |
_version_ | 1782373932981026816 |
---|---|
author | Colombo, L. Sala, B. Montesano, G. Pierrottet, C. De Cillà, S. Maltese, P. Bertelli, M. Rossetti, L. |
author_facet | Colombo, L. Sala, B. Montesano, G. Pierrottet, C. De Cillà, S. Maltese, P. Bertelli, M. Rossetti, L. |
author_sort | Colombo, L. |
collection | PubMed |
description | To portray Usher Syndrome type 2, analyzing choroidal thickness and comparing data reported in published literature on RP and healthy subjects. Methods. 20 eyes of 10 patients with clinical signs and genetic diagnosis of Usher Syndrome type 2. Each patient underwent a complete ophthalmologic examination including Best Corrected Visual Acuity (BCVA), intraocular pressure (IOP), axial length (AL), automated visual field (VF), and EDI OCT. Both retinal and choroidal measures were measured. Statistical analysis was performed to correlate choroidal thickness with age, BCVA, IOP, AL, VF, and RT. Comparison with data about healthy people and nonsyndromic RP patients was performed. Results. Mean subfoveal choroidal thickness (SFCT) was 248.21 ± 79.88 microns. SFCT was statistically significant correlated with age (correlation coefficient −0.7248179, p < 0.01). No statistically significant correlation was found between SFCT and BCVA, IOP, AL, VF, and RT. SFCT was reduced if compared to healthy subjects (p < 0.01). No difference was found when compared to choroidal thickness from nonsyndromic RP patients (p = 0.2138). Conclusions. Our study demonstrated in vivo choroidal thickness reduction in patients with Usher Syndrome type 2. These data are important for the comprehension of mechanisms of disease and for the evaluation of therapeutic approaches. |
format | Online Article Text |
id | pubmed-4449934 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-44499342015-06-14 Choroidal Thickness Analysis in Patients with Usher Syndrome Type 2 Using EDI OCT Colombo, L. Sala, B. Montesano, G. Pierrottet, C. De Cillà, S. Maltese, P. Bertelli, M. Rossetti, L. J Ophthalmol Research Article To portray Usher Syndrome type 2, analyzing choroidal thickness and comparing data reported in published literature on RP and healthy subjects. Methods. 20 eyes of 10 patients with clinical signs and genetic diagnosis of Usher Syndrome type 2. Each patient underwent a complete ophthalmologic examination including Best Corrected Visual Acuity (BCVA), intraocular pressure (IOP), axial length (AL), automated visual field (VF), and EDI OCT. Both retinal and choroidal measures were measured. Statistical analysis was performed to correlate choroidal thickness with age, BCVA, IOP, AL, VF, and RT. Comparison with data about healthy people and nonsyndromic RP patients was performed. Results. Mean subfoveal choroidal thickness (SFCT) was 248.21 ± 79.88 microns. SFCT was statistically significant correlated with age (correlation coefficient −0.7248179, p < 0.01). No statistically significant correlation was found between SFCT and BCVA, IOP, AL, VF, and RT. SFCT was reduced if compared to healthy subjects (p < 0.01). No difference was found when compared to choroidal thickness from nonsyndromic RP patients (p = 0.2138). Conclusions. Our study demonstrated in vivo choroidal thickness reduction in patients with Usher Syndrome type 2. These data are important for the comprehension of mechanisms of disease and for the evaluation of therapeutic approaches. Hindawi Publishing Corporation 2015 2015-05-17 /pmc/articles/PMC4449934/ /pubmed/26075083 http://dx.doi.org/10.1155/2015/189140 Text en Copyright © 2015 L. Colombo et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Colombo, L. Sala, B. Montesano, G. Pierrottet, C. De Cillà, S. Maltese, P. Bertelli, M. Rossetti, L. Choroidal Thickness Analysis in Patients with Usher Syndrome Type 2 Using EDI OCT |
title | Choroidal Thickness Analysis in Patients with Usher Syndrome Type 2 Using EDI OCT |
title_full | Choroidal Thickness Analysis in Patients with Usher Syndrome Type 2 Using EDI OCT |
title_fullStr | Choroidal Thickness Analysis in Patients with Usher Syndrome Type 2 Using EDI OCT |
title_full_unstemmed | Choroidal Thickness Analysis in Patients with Usher Syndrome Type 2 Using EDI OCT |
title_short | Choroidal Thickness Analysis in Patients with Usher Syndrome Type 2 Using EDI OCT |
title_sort | choroidal thickness analysis in patients with usher syndrome type 2 using edi oct |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449934/ https://www.ncbi.nlm.nih.gov/pubmed/26075083 http://dx.doi.org/10.1155/2015/189140 |
work_keys_str_mv | AT colombol choroidalthicknessanalysisinpatientswithushersyndrometype2usingedioct AT salab choroidalthicknessanalysisinpatientswithushersyndrometype2usingedioct AT montesanog choroidalthicknessanalysisinpatientswithushersyndrometype2usingedioct AT pierrottetc choroidalthicknessanalysisinpatientswithushersyndrometype2usingedioct AT decillas choroidalthicknessanalysisinpatientswithushersyndrometype2usingedioct AT maltesep choroidalthicknessanalysisinpatientswithushersyndrometype2usingedioct AT bertellim choroidalthicknessanalysisinpatientswithushersyndrometype2usingedioct AT rossettil choroidalthicknessanalysisinpatientswithushersyndrometype2usingedioct |